sv  no  en  

Prevas streamlines Q-Med deliveries

Prevas and Q-Med, a fast-growing and profitable biotechnology/medical device company, have
signed an agreement on supply of a traceability system for Q-Med´s central warehouse in Uppsala,

Q-Med is a highly successful company which develops, produces, markets and sells medical
implants. The company is in a phase of rapid growth and needs to streamline its delivery processes
to be able to continue its expansion. The Prevas IT solution provides efficient processing and
integrates Q-Med´s warehouse with the company´s ERP system to provide real-time stock level
information. Prevas´ cost-effective IT solutions are based on over 20 years of experience of
warehouse management packages as a standard product. Prevas´ contract with Q-Med involves
supply of a complete system for automatic data capture with PDAs and printers, plus validation to
comply with official requirements. Q-Med has an option for introducing the same system for all its
subsidiaries globally.

“Prevas´ system provides real rationalisation and a cost-effective solution which can quickly be
replicated for all our subsidiaries, plus Prevas´ experience within validation for biotech industry IT
systems gives us assured delivery", says Pär Björkén, Q-Med Logistics Manager.
“Prevas will improve profitability for the company by supplying modern, efficient IT solutions for
automation, logistics and traceability. Q-Med is highly successful and an important new customer,
and we look forward to a successful partnership," says Anders Englund, CEO of Prevas.

About Prevas

Prevas develops intelligence in products and industrial systems. Prevas is a project-oriented, hi-tech IT company. The company offers consultancy services, products and support to companies developing products with a large IT content or which need to streamline or automate their business. Prevas solutions are renowned for their reliable delivery and quality.
Prevas is listed on the Stockholm Stock Exchange.
See also

About Q-Med

Q-Med is a rapidly growing and profitable biotechnology/medical device company, which develops, produces, markets and sells medical implants. All products are based on the company´s patented technology for the production of stabilised nonanimal hyaluronic acid NASHA™. Q-Med today has just over 560 co-workers, with approx. 370 at the company´s head office and production facility in Uppsala, Sweden. The Q-Med share is listed on the Stockholm Stock Exchange.
See also

Kontakt Prevas A/S for mere information:

Produkt log ind


Med spidskompetence inden
for indlejrede systemer og
industriel IT bidrager Prevas
med innovative løsninger,
der skaber vækst